Option Care Health (NASDAQ:OPCH) Announces Earnings Results

Option Care Health (NASDAQ:OPCH) announced its earnings results on Wednesday. The company reported $0.35 EPS for the quarter, topping the consensus estimate of $0.33 by $0.02, Zacks reports. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%.

Option Care Health Price Performance

NASDAQ OPCH traded up $0.51 during trading on Wednesday, hitting $33.14. 1,459,994 shares of the stock traded hands, compared to its average volume of 1,734,869. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.17. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a 50-day simple moving average of $28.07 and a 200-day simple moving average of $28.00. The company has a market capitalization of $5.64 billion, a P/E ratio of 27.89, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. UBS Group assumed coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Barrington Research boosted their target price on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 14th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, Truist Financial dropped their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average target price of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.